19446868

Source:http://linkedlifedata.com/resource/pubmed/id/19446868

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035648, umls-concept:C0278689, umls-concept:C0549410, umls-concept:C0717726, umls-concept:C1292734, umls-concept:C1522326
pubmed:issue	2
pubmed:dateCreated	2009-6-29
pubmed:abstractText	Pegylated liposomal doxorubicin (PLD) was introduced to reduce the adverse effect of doxorubicin in treating recurrent ovarian cancer. We sought to characterize the efficacy and adverse-effect profile of PLD in different doses and to evaluate predictive factors of palmar-plantar erythrodysesthesia (PPE).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0365304
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/pegylated liposomal doxorubicin
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1095-6859
pubmed:author	pubmed-author:MunsellMark FMF, pubmed-author:ParkerCrystal LCL, pubmed-author:RamosLafitL, pubmed-author:SmithJudith AJA, pubmed-author:TanyiJanos LJL, pubmed-author:WolfJudith KJK
pubmed:issnType	Electronic
pubmed:volume	114
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	219-24
pubmed:meshHeading	pubmed-meshheading:19446868-Adult, pubmed-meshheading:19446868-Aged, pubmed-meshheading:19446868-Aged, 80 and over, pubmed-meshheading:19446868-Antibiotics, Antineoplastic, pubmed-meshheading:19446868-Dose-Response Relationship, Drug, pubmed-meshheading:19446868-Doxorubicin, pubmed-meshheading:19446868-Drug Administration Schedule, pubmed-meshheading:19446868-Drug Eruptions, pubmed-meshheading:19446868-Erythema, pubmed-meshheading:19446868-Female, pubmed-meshheading:19446868-Foot Dermatoses, pubmed-meshheading:19446868-Hand Dermatoses, pubmed-meshheading:19446868-Humans, pubmed-meshheading:19446868-Middle Aged, pubmed-meshheading:19446868-Ovarian Neoplasms, pubmed-meshheading:19446868-Paresthesia, pubmed-meshheading:19446868-Polyethylene Glycols, pubmed-meshheading:19446868-Retrospective Studies, pubmed-meshheading:19446868-Risk Factors, pubmed-meshheading:19446868-Young Adult
pubmed:year	2009
pubmed:articleTitle	Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
pubmed:affiliation	Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77230-1439, USA.
pubmed:publicationType	Journal Article